Joint XXXVII Italian Society of Allergology, Asthma, and Clinical Immunology (SIAAIC) National Congress and World Allergy Organization Congress (WAO)

Oct 3 - Oct 5, 2025

  • Title: Efficacy and Safety of Oral Deucrictibant for Prophylaxis and On-Demand Treatment of Attacks in Acquired Angioedema with C1 Inhibitor Deficiency: CREAATE Phase 3 Trial Design
    Presenter: Mauro Cancian, M.D., Ph.D.
    Format: Poster Presentation, #39
    Date, Time: Friday, October 3, 7:00-8:00 p.m. CET (1:00-2:00 p.m. ET)
  • Title: Long-Term Safety and Efficacy of Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Data Snapshot Results of the CHAPTER-1 Open-Label Extension Study
    Presenter: Andrea Zanichelli, M.D., Ph.D.
    Format: Poster Presentation, #248
    Date, Time: Sunday, October 5, 1:30-2:30 p.m. CET (7:30-8:30 a.m. ET)
  • Title: Long-Term Safety and Efficacy of Oral Deucrictibant for Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study
    Presenter: Giuseppe Spadaro, M.D.
    Format: Poster Presentation, #213
    Date, Time: Sunday, October 5, 1:30-2:30 p.m. CET (7:30-8:30 a.m. ET)